Skip to main content
Clinical Trials/NCT05236907
NCT05236907
Completed
Not Applicable

The Efficacy of Oral Melatonin in Preventing Postoperative Delirium for Patients Undergoing Orthopedic Surgery Under General Anesthesia

University of Baghdad2 sites in 1 country36 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
No intervention
Conditions
Delirium, Anesthesia Emergence
Sponsor
University of Baghdad
Enrollment
36
Locations
2
Primary Endpoint
The efficacy of oral Melatonin in preventing Postoperative Delirium after general anesthesia
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Postoperative delirium is a complication that should not be underestimated. As it elaborates many complications that could be avoided when an accurate assessment of the risk factors and interventional measures are taken appropriately when needed.

Detailed Description

Delirium is a variation in concentration capabilities that occurs acutely in association with a disturbed level of consciousness. Delirium is more common in orthopaedic surgery patients than in general surgery patients. As delirium ratios range from 44% to 55% in hip surgery patients, otherwise only 10%-14% of general surgery patients. Several studies were carried out and found that melatonin levels correlate with the development of delirium postoperatively. This study was conducted to determine the efficacy of administering melatonin preoperatively in patients undergoing orthopedic surgery to prevent postoperative delirium.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
November 1, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hashim Talib Hashim

Principal Investigator

University of Baghdad

Eligibility Criteria

Inclusion Criteria

  • 1- Patients in good general health.
  • Baseline MDAS \<
  • No seizure disorder.

Exclusion Criteria

  • Patients with a neurological disorder (e.g., dementia, stroke, epilepsy).
  • Patients with a history of acute or chronic confusion.
  • Patients taking centrally acting drugs (e.g., antidepressants, antiparkinsonian drugs, sedatives, monoamine oxidase inhibitors), or alcohol abusers.
  • Patients who have medical disorders predisposing to delirium (e.g. cachexia, thyroid dysfunction, renal failure).

Arms & Interventions

Control Group

Patients in this group received nothing for sedation.

Intervention: No intervention

Midazolam group

7.5 mg of Midazolam were given orally the night before operation. Another dose 90 min. preoperatively.

Intervention: Midazolam

Melatonin group

5 mg of Melatonin were given orally the night before operation. Another dose 90 min. preoperatively

Intervention: Melatonin

Outcomes

Primary Outcomes

The efficacy of oral Melatonin in preventing Postoperative Delirium after general anesthesia

Time Frame: 1 week

This interventional trial is done to determine the efficacy of preoperative melatonin administration in reducing postoperative delirium rates.

Study Sites (2)

Loading locations...

Similar Trials